Zealand and Dexom has contributed to a $13m extension to the artificial pancreas developer's series B round, which also includes Novo Nordisk.

Tencent and CLP Fund helped provide $58.8m of funding for the cancer data platform developer, whose early investors include Ping An.

Celgene has taken part in a Harel Insurance Finance-led series B round that will fund the progress of Biond's lead immuno-oncology drug into clinical trials.

SleepScore Labs and parent company ResMed have formed SleepScore Ventures to fund and support startups developing technology and products aimed at improving sleep quality.

Merck GHI managing director Francesca Wuttke has joined Almirall to lead the drug producer's digital transformation efforts.

Perry Robinson, a managing director at corporate venturing unit GIS Strategic Venture Capital, has rejoined venture firm Greenwich BioMedical Digital Health Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Genomics data management and analysis platform DNAStack has secured a follow-on investment from Facit, building on the commercialisation unit's initial commitment in 2017.

Keros Therapeutics will use the proceeds from the Partners Healthcare and Medison Pharma-backed round to push its rare muscle disease drugs into clinical trials.

The Intel Capital-backed pharmaceutical e-commerce platform has begun raising a new funding round that would reportedly value the company at $200m.